These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28087588)

  • 1. Bleeding associated with the management of acute coronary syndromes.
    De Silva K; Myat A; Cotton J; James S; Gershlick A; Stone GW
    Heart; 2017 Apr; 103(7):546-562. PubMed ID: 28087588
    [No Abstract]   [Full Text] [Related]  

  • 2. Strategies to reduce bleeding risk in acute coronary syndromes and percutaneous coronary intervention: new and emerging pharmacotherapeutic considerations.
    Coons JC; Miller T
    Pharmacotherapy; 2014 Sep; 34(9):973-90. PubMed ID: 24898316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reduction of haemorrhagic risk in acute coronary syndromes].
    Merino A; Roldán I; Marín F; Worner F;
    Med Clin (Barc); 2011 Nov; 137(14):650-5. PubMed ID: 20701931
    [No Abstract]   [Full Text] [Related]  

  • 4. Minimizing the risks of anticoagulants and platelet inhibitors.
    Alexander KP; Peterson ED
    Circulation; 2010 May; 121(17):1960-70. PubMed ID: 20439812
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessing bleeding risk in acute coronary syndromes.
    Erdem G; Flather M
    Rev Esp Cardiol (Engl Ed); 2012 Jan; 65(1):4-6. PubMed ID: 22056593
    [No Abstract]   [Full Text] [Related]  

  • 6. Introduction. Key issues surrounding the treatment of acute coronary syndromes (ACS).
    Gibson CM; Watkins B; Merlo K
    J Interv Cardiol; 2008 Dec; 21 Suppl 1():S1-2. PubMed ID: 19090931
    [No Abstract]   [Full Text] [Related]  

  • 7. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
    Rubboli A; Halperin JL
    Thromb Haemost; 2008 Nov; 100(5):752-3. PubMed ID: 18989515
    [No Abstract]   [Full Text] [Related]  

  • 8. Bleeding complications in patients with acute coronary syndromes: are they important and how can we prevent them?
    Amin F; Jolly S
    Hosp Pract (1995); 2012 Apr; 40(2):96-103. PubMed ID: 22615084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of anticoagulation regimen prior to revascularization in patients with non-ST-segment elevation acute coronary syndromes: The ACUITY trial.
    Geisler T; Droppa M; Gawaz M; Steinhubl SR; Bertrand ME; Lincoff AM; Cequier AR; Desmet W; Rasmussen LH; Hoekstra JW; Bernstein D; Deliargyris EN; Mehran R; Stone GW
    Catheter Cardiovasc Interv; 2016 Aug; 88(2):174-81. PubMed ID: 26332193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.
    Roldán V; Marín F
    Thromb Haemost; 2008 Nov; 100(5):754-5. PubMed ID: 18989516
    [No Abstract]   [Full Text] [Related]  

  • 11. The Benefits and Risks of Oral Antiplatelet Therapy in Patients with Acute Coronary Syndrome.
    Ahmad T; Davies R; Alagona P
    J Fam Pract; 2017 Feb; 66(2 Suppl):. PubMed ID: 29095443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleeding Academic Research Consortium consensus report: the Food and Drug Administration perspective.
    Hicks KA; Stockbridge NL; Targum SL; Temple RJ
    Circulation; 2011 Jun; 123(23):2664-5. PubMed ID: 21670240
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of timing of clopidogrel treatment on the efficacy and safety of bivalirudin in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention: an analysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
    Lincoff AM; Steinhubl SR; Manoukian SV; Chew D; Pollack CV; Feit F; Ware JH; Bertrand ME; Ohman EM; Desmet W; Cox DA; Mehran R; Stone GW;
    JACC Cardiovasc Interv; 2008 Dec; 1(6):639-48. PubMed ID: 19463378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between bleeding and mortality among women and men with high-risk acute coronary syndromes: insights from the Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes (EARLY ACS) trial.
    Kaul P; Tanguay JF; Newby LK; Hochman JS; Westerhout CM; Califf RM; Tricoci P; Gibson CM; Giugliano RP; Harrington RA; Van de Werf F; Armstrong PW
    Am Heart J; 2013 Oct; 166(4):723-8. PubMed ID: 24093853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of clopidogrel after PCI with stenting in patients on oral anticoagulants with acute coronary syndrome.
    Persson J; Lindbäck J; Hofman-Bang C; Lagerqvist B; Stenestrand U; Samnegard A
    EuroIntervention; 2011 Apr; 6(9):1046-52, 8-9. PubMed ID: 21518675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of chronic antiplatelet therapy before hospitalization on ischemic and bleeding events in invasively managed patients with acute coronary syndromes: the ACUITY trial.
    Ambrosio G; Steinhubl S; Gresele P; Tritto I; Zuchi C; Bertrand ME; Lincoff AM; Moses JW; Ohman EM; White HD; Mehran R; Stone GW
    Eur J Cardiovasc Prev Rehabil; 2011 Feb; 18(1):121-8. PubMed ID: 20523219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleeding risks with prasugrel in the TRITON trial: good news ... bad news.
    Serebruany VL
    Cardiology; 2008; 111(4):265-7. PubMed ID: 18434736
    [No Abstract]   [Full Text] [Related]  

  • 18. Gastrointestinal bleeding in percutaneous coronary intervention and acute coronary syndromes.
    Nikolsky E; Mehran R; Stone GW
    Am J Cardiol; 2009 Sep; 104(5 Suppl):22C-9C. PubMed ID: 19695357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of novel and emerging oral anticoagulants for secondary prevention of acute coronary syndromes.
    Ganetsky VS; Hadley DE; Thomas TF
    Pharmacotherapy; 2014 Jun; 34(6):590-604. PubMed ID: 24338703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic therapy for non ST-segment elevation acute coronary syndromes: focus on antithrombotic therapy.
    Danchin N; Aïssaoui N
    Cardiovasc Drugs Ther; 2010 Aug; 24(4):325-30. PubMed ID: 20714797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.